High Serum B Cell Activating Factor Predicts Good Clinical Response to Rituximab in RA: Pilot Data
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2010.129585b
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2010
Authors
Publisher
BMJ